Status | Study |
Recruiting |
Study Name: FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas Condition: Gastro-enteropancreatic Neuroendocrine Tumor Pancreatic Cancer Date: 2017-02-02 Interventions: Drug: FOLFIRINOX The FOLFIRINO |
Recruiting |
Study Name: Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery Condition: Pancreatic Neuroendocrine Tumor G1 Pancreatic Neuroendocrine Tumor G2 Date: 2016-09-08 Interventions: Drug: Sapanisertib Given PO Other Names: |
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
Recruiting |
Study Name: Clinical Evaluation of i-STAT Analyzer Condition: Diabetes Mellitus Neonatal Hypoglycemia Pancreatic Date: 2016-07-06 |
Recruiting |
Study Name: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insulinoma Date: 2014-10-03 Interventions: Drug: regorafenib Given PO |
Recruiting |
Study Name: Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II Condition: Pancreatic Neuroendocrine Carcinoma Date: 2014-08-27 Interventions: Drug: Sunitinib Drug: 177Lu-DOTA0-Tyr3-Oct |
Active, not recruiting |
Study Name: Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery Condition: Multiple Endocrine Neoplasia Type 1 Pancreatic Neuroendocrine Carcinom Date: 2014-03-28 Interventions: Radiation: Computed Tomography Perfusion Imaging |
Withdrawn |
Study Name: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insulinoma Date: 2014-01-07 Interventions: Drug: dovitinib lactate Given |
Terminated |
Study Name: Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery Condition: Gastrinoma Glucagonoma Insulinoma Date: 2014-01-07 Interventions: Drug: everolimus Given PO |
Active, not recruiting |
Study Name: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insulinoma Date: 2013-04-02 Interventions: Drug: temozolomide Given PO |